Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 29, 2025: -0.89%

Charles River Laboratories International, Inc. Return on Equity (ROE) is -0.89% for the Trailing 12 Months (TTM) ending March 29, 2025, a -107.01% change year over year. Return on equity measures profit against shareholder equity; higher ROE indicates superior profitability and value creation.
  • Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 30, 2024 was 12.72%, a -27.20% change year over year.
  • Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending April 01, 2023 was 17.48%, a 2.29% change year over year.
  • Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 26, 2022 was 17.09%, a -9.48% change year over year.
  • Charles River Laboratories International, Inc. Return on Equity (ROE) for the Trailing 12 Months (TTM) ending March 27, 2021 was 18.88%, a 19.55% change year over year.
Key Data
Date Return on Equity (ROE) Return on Assets (ROA) Revenue Per Share Free Cash Flow Per Share